Increased urinary excretion of the prostaglandin D2 metabolite 9α,11β-prostaglandin F2 after aspirin challenge supports mast cell activation in aspirin-induced airway obstruction
- 1 August 1996
- journal article
- clinical trial
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 98 (2) , 421-432
- https://doi.org/10.1016/s0091-6749(96)70167-7
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Direct evidence for a role of the mast cell in the nasal response to aspirin in aspirin-sensitive asthmaJournal of Allergy and Clinical Immunology, 1994
- The leukotriene-antagonist ICI-204,219 inhibits the early airway reaction to cumulative bronchial challenge with allergen in atopic asthmaticsEuropean Respiratory Journal, 1994
- Effect of the leukotriene receptor antagonist MK-0679 on baseline pulmonary function in aspirin sensitive asthmatic subjects.Thorax, 1993
- Tryptase and histamine release during aspirin-induced respiratory reactionsJournal of Allergy and Clinical Immunology, 1991
- Release of Prostaglandin D2into Human Airways during Acute Antigen ChallengeNew England Journal of Medicine, 1986
- Diagnosis, prevention, and treatment of adverse reactions to aspirin and nonsteroidal anti-inflammatory drugsJournal of Allergy and Clinical Immunology, 1984
- Increased Production of Prostaglandin D2 in Patients with Systemic MastocytosisNew England Journal of Medicine, 1980
- An Analysis of the Role of IgE in Intolerance to Aspirin and TartrazineAllergy, 1978
- Relationship of inhibition of prostaglandin biosynthesis by analgesics to asthma attacks in aspirin-sensitive patients.BMJ, 1975
- RELEASE OF HISTAMINE IN URTICARIA PIGMENTOSAThe Lancet, 1957